Abstract
The results of previous studies on the relationship between leptin and blood pressure are discordant. We investigated to what extent the serum leptin level was related to blood pressure independent of the degree of insulin resistance. The subjects were 1,916 men aged 34–69 years whose mean body mass index (BMI) was 23.0 kg/m2. Blood pressure was regressed by leptin concentrations with adjustments for age, BMI, insulin resistance, triglyceride, high density lipoprotein cholesterol, low density lipoprotein cholesterol, physical activity, drinking habits and smoking status. Leptin was associated with diastolic blood pressure (DBP) (standardized β: 0.092, p=0.003), but not with systolic blood pressure (SBP) (standardized β: 0.035, p=0.25), although insulin resistance was positively associated with both SBP and DBP (standardized β: 0.175 for SBP, p<0.001 and 0.114 for DBP, p<0.001) among all subjects. After subjects were divided into those with normal blood pressure (SBP<130 mmHg and DBP<85 mmHg) and those with higher blood pressure, leptin was positively and significantly associated with DBP (standardized β: 0.106, p=0.012) independent of the degree of insulin resistance, but not with SBP (standardized β: 0.064, p=0.13) among subjects in the normal blood pressure range. Among the subjects with higher blood pressure, however, neither the association of leptin with SBP nor that of leptin with DBP was statistically significant. These findings suggest that leptin may maintain and increase arterial tone, resulting in the elevation of DBP only within normal blood pressure range. It is also likely that leptin is a physiological mediator—or at least a marker—of some degree of DBP elevation in obesity.
Similar content being viewed by others
Article PDF
References
Montani JP, Antic V, Yang Z, Dulloo A : Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 2002; 26: S28–S38.
Aihara A, Imai Y, Sekino M, et al: Discrepancy between screening blood pressure and ambulatory blood pressure: a community-based study in Ohasama. Hypertens Res 1998; 21: 127–136.
Masuo K, Mikami H, Ogihara T, Tuck ML : Weight gain–induced blood pressure elevation. Hypertension 2000; 35: 1135–1140.
Flaa A, Mundal HH, Eide I, Kjeldsen S, Rostrup M : Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges. Hypertension 2006; 47: 396–402.
Kaushik RM, Mahajan SK, Rajesh V, Kaushik R : Stress profile in essential hypertension. Hypertens Res 2004; 27: 619–624.
Shek EW, Brands MW, Hall JE : Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409–414.
Casto RM, VanNess JM, Overton JM : Effects of central leptin administration on blood pressure in normotensive rats. Neurosci Lett 1998; 246: 29–32.
Agata J, Masuda A, Takada M, et al: High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10: 1171–1174.
Sheu WHH, Lee WJ, Chen YT : High plasma leptin concentrations in hypertensive men but not in hypertensive women. J Hypertens 1999; 17: 1289–1295.
de Courten M, Zimmet P, Hodge A, et al: Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med 1997; 14: 200–208.
Barba G, Russo O, Siani A, et al: Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res 2003; 11: 160–166.
Hirose H, Saito I, Tsujioka M, Mori M, Kawabe H, Saruta T : The obese gene product, leptin: possible role in obesity-related hypertension in adolescents. J Hypertens 1998; 16: 2007–2012.
Takizawa H, Ura N, Saitoh S, et al: Gender difference in the relationships among hyperleptinemia, hyperinsulinemia, and hypertension. Clin Exp Hypertens 2001; 23: 357–368.
Itoh K, Imai K, Masuda T, et al: Relationship between changes in serum leptin levels and blood pressure after weight loss. Hypertens Res 2002; 25: 881–886.
Hu FB, Chen C, Wang B, Stampfer MJ, Xu X : Leptin concentrations in relation to overall adiposity, fat distribution, and blood pressure in a rural Chinese population. Int J Obes Relat Metab Disord 2001; 25: 121–125.
El-Gharbawy AH, Kotchen JM, Grim CE, et al: Gender-specific correlates of leptin with hypertension-related phenotypes in African Americans. Am J Hypertens 2002; 15: 989–993.
Mallamaci F, Cuzzola F, Tripepi G, et al: Gender-dependent differences in plasma leptin in essential hypertension. Am J Hypertens 2000; 13: 914–920.
Aizawa-Abe M, Ogawa Y, Masuzaki H, et al: Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000; 105: 1243–1252.
Sung KC, Kim BJ, Kim BS, et al: In normoglycemic Koreans, insulin resistance and adipocity are independently correlated with high blood pressure. Circ J 2004; 68: 898–902.
Verma S, Bhanot S, McNeill JH : Sympathectomy prevents fructose-induced hyperinsulinemia and hypertension. Eur J Pharmacol 1999; 373: R1–R4.
Galipeau D, Arikawa E, Sekirov I, McNeill JH : Chronic thromboxane synthase inhibition prevents fructose-induced hypertension. Hypertension 2001; 38: 872–876.
Vecchione C, Aretini A, Maffei A, et al: Cooperation between insulin and leptin in the modulation of vascular tone. Hypertension 2003; 42: 166–170.
Kolaczynski JW, Nyce MR, Considine RV, et al: Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 1996; 45: 699–701.
Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI : Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100: 270–278.
Fruhbeck G : Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 1999; 48: 903–908.
Matsuda K, Teragawa H, Fukuda Y, Nakagawa K, Higashi Y, Chayama K : Leptin causes nitric-oxide independent coronary artery vasodilation in humans. Hypertens Res 2003; 26: 147–152.
Zanetti M, Barazzoni R, Vadori M, Stebel M, Biolo G, Guarnieri G : Lack of direct effect of moderate hyperleptinemia to improve endothelial function in lean rat aorta: role of calorie restriction. Atherosclerosis 2004; 175: 253–259.
Beltowski J, Wojcicka G, Jamroz A : Stimulatory effect of leptin on nitric oxide production is impaired in dietary-induced obesity. Obes Res 2003; 11: 1571–1580.
Yatsuya H, Tamakoshi K, Hattori H, et al: Serum phospholipid transfer protein mass as a possible protective factor for coronary heart diseases. Circ J 2004; 68: 11–16.
Mabuchi T, Yatsuya H, Tamakoshi K, et al: Association between serum leptin concentration and white blood cell count in middle-aged Japanese men and women. Diabetes Metab Res Rev 2005; 21: 441–447.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC : Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
European Society of Hypertension-European Society of Cardiology Guidelines Committee : 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.
Japanese Society of Hypertension Guidelines Subcommittee for the Management of Hypertension : Guidelines for the management of hypertension for general practitioners. Hypertens Res 2001; 24: 613–634.
Kim-Motoyama H, Yamaguchi T, Katakura T, et al: Serum leptin levels are associated with hyperinsulinemia independent of body mass index but not with visceral obesity. Biochem Biophys Res Commun 1997; 239: 340–344.
Zimmet PZ, Collins VR, de Courten MP, et al, Mauritius NCD Study Group: Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius. Int J Obes Relat Metab Disord 1998; 22: 171–177.
Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M : Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996; 45: 695–698.
Mark AL, Shaffer RA, Correia ML, Morgan DA, Sigmund CD, Haynes WG : Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens 1999; 17: 1949–1953.
Bornstein SR, Torpy DJ : Leptin and the renin-angiotensin-aldosterone system. Hypertension 1998; 32: 376–377.
Jackson EK, Li P : Human leptin has natriuretic activity in the rat. Am J Physiol 1997; 272: F333–F338.
Suter PM, Locher R, Hasler E, Vetter W : Is there a role for the ob gene product leptin in essential hypertension? Am J Hypertens 1998; 11: 1305–1311.
Corica F, Corsonello A, Ientile R, et al: Leptin and norepinephrine plasma concentrations during glucose loading in normotensive and hypertensive obese women. Am J Hypertens 2001; 14: 619–626.
Eikelis N, Schlaich M, Aggarwal A, Kaye D, Esler M : Interactions between leptin and the human sympathetic nervous system. Hypertension 2003; 41: 1072–1079.
Narkiewicz K, Kato M, Phillips BG, et al: Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects. J Hypertens 2001; 19: 1089–1094.
Fogari R, Derosa G, Zoppi A, et al: Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients. Hypertens Res 2005; 28: 209–214.
Nishina M, Kikuchi T, Yamazaki H, Kameda K, Hiura M, Uchiyama M : Relationship among systolic blood pressure, serum insulin and leptin, and visceral fat accumulation in obese children. Hypertens Res 2003; 26: 281–288.
Tank J, Jordan J, Diedrich A, et al: Bound leptin and sympathetic outflow in nonobese men. J Clin Endocrinol Metab 2003; 88: 4955–4959.
Sinha MK, Opentanova I, Ohannesian JP, et al: Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996; 98: 1277–1282.
Sandhofer A, Laimer M, Ebenbichler CF, Kaser S, Paulweber B, Patsch JR : Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. Obes Res 2003; 11: 760–768.
Knudson JD, Dincer UD, Zhang C, et al: Leptin receptors are expressed in coronary arteries and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol 2005; 289: H48–H56.
Smulyan H, Safar ME : The diastolic blood pressure in systolic hypertension. Ann Intern Med 2000; 132: 233–237.
Kirpichnikov D, Sowers JR : Role of ACE inhibitors in treating hypertensive diabetic patients. Curr Diab Rep 2002; 2: 251–257.
Imazu M : Hypertension and insulin disorders. Curr Hypertens Rep 2002; 4: 477–482.
Bonora E, Targher G, Alberiche M, et al: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57–63.
Haffner SM, Gingerich RL, Miettinen H, Stern MP : Leptin concentrations in relation to overall adiposity and regional body fat distribution in Mexican Americans. Int J Obes Relat Metab Disord 1996; 20: 904–908.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wada, K., Yatsuya, H., Tamakoshi, K. et al. A Positive Association between Leptin and Blood Pressure of Normal Range in Japanese Men. Hypertens Res 29, 485–492 (2006). https://doi.org/10.1291/hypres.29.485
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.29.485